NCT02302092View on ClinicalTrials.gov

An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections

PHASE3TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

February 2, 2016

Study Completion Date

December 15, 2016

Conditions
Urinary Tract Infection
Interventions
DRUG

Flomoxef

Flomoxef intravenous infusion

DRUG

Cefepime

Cefepime intravenous infusion

Trial Locations (5)

Unknown

Moscow

Rostov-on-Don

Saint Petersburg

Volgograd

Yaroslavl

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02302092 - An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections | Biotech Hunter | Biotech Hunter